Vivitrol Alternatives Compared
| Vivitrol (naltrexone) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|---|
| Vivitrol (naltrexone) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Vivitrol is used for the treatment of alcohol or opioid addiction alongside social therapy and psychotherapy. It is administered by intramuscular injection by a health professional once every four... View more |
Prescription only
Suboxone is a combination medicine containing buprenorphine and naloxone that is used to treat adults addicted to opioid medications. It should be used in conjunction with a complete treatment... View more |
Prescription only
Buprenorphine/naloxone is a combination opioid/opioid antagonist tablet which helps to suppress opioid withdrawal symptoms and is used for the maintenance treatment of opioid drug dependence... View more |
Related suggestions Opioid Use Disorder
|
|||||||||||||||||||||||
| More about Vivitrol (naltrexone) | More about Suboxone (buprenorphine / naloxone) | More about Buprenorphine / naloxone | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Vivitrol has an average rating of 7.5 out of 10 from a total of 203 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 20% reported a negative effect. |
Suboxone has an average rating of 8.5 out of 10 from a total of 729 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 7% reported a negative effect. |
Buprenorphine / naloxone has an average rating of 7.7 out of 10 from a total of 1131 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Vivitrol side effects |
View all Suboxone side effects |
|
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Vivitrol prices |
View all Suboxone prices |
View all Buprenorphine / naloxone prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other buprenorphine / naloxone brands include: Zubsolv | Suboxone, Zubsolv | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
10 hours |
37 hours |
37 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 349 drugs are known to interact with Vivitrol:
|
A total of 721 drugs are known to interact with Suboxone:
|
A total of 721 drugs are known to interact with Buprenorphine / naloxone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 13, 2006 |
October 08, 2002 |
October 08, 2002 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.